PERPHENAZINE (perphenazine) by Pfizer is clinical pharmacology pharmacokinetics following oral administration of perphenazine tablets, usp mean peak plasma perphenazine concentrations were observed between 1 to 3 hours. Approved for schizophrenia. First approved in 2015.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY Pharmacokinetics Following oral administration of perphenazine tablets, USP mean peak plasma perphenazine concentrations were observed between 1 to 3 hours. The plasma elimination half-life of perphenazine was independent of dose and ranged between 9 and 12 hours. In a study…
Phenothiazine
Worked on PERPHENAZINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer